Merieux Equity Partners Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, Merieux Equity Partners has acquired 4 companies. It has also invested in 3 others.

Merieux Equity Partners’ most common sectors for investment arelife science (50%) and medical products (15%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (35%) and growth capital (30%). In total, Merieux Equity Partners has invested in 1 US state and 8 different countries.

In the last 3 years, Merieux Equity Partners has exited 3 companies. The Firm’s most common exit type is trade sale (40%).

Join Mergr to view Merieux Equity Partners’ full profile and discover more large growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity25
    • M&A Buy Activity20
    • M&A Sell Activity5
  • Total Sectors Invested 7
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 9
  • M&A Advisors 4

Merieux Equity Partners

3, Rue Marcel Gabriel Rivière ,
Lyon, 69002
France
+33 4 78 87 37 00
www.merieux-developpement.com
info@merieux-partners.com

Mérieux Développement SAS is a venture and growth capital investment firm associated with family holding company Institut Mérieux. The Firm focuses on the health and nutrition sectors and will consider opportunities throughout North America and Europe. Mérieux Développement SAS was established in 2009 and is headquartered in Lyon, France.


Investment Criteria

Sectors of Interest: Chemicals, Healthcare Services, Life Science, Medical Products

Target Transaction Types: Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Nordic, Middle East

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 20 80
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.8/yr) # 11 2 4 1 1 1 20
Sell (0.6/yr) # 2 - - 1 - 2 5
  25

Most Recent M&A

Company Date Value Type
GTP Bioways SAS 2024-07-03 - Trade Sale
Toulouse , France · www.gtp-bioways.com
InnoSyn B.V. 2024-02-05 - Buyout (LBO, MBO, MBI)
Geleen, Netherlands · www.innosyn.com
Mabtech AB 2024-01-09 - Secondary Sale
Nacka Strand, Sweden · www.mabtech.com
Piercan 2023-03-21 - Buyout (LBO, MBO, MBI)
San Marcos, California · www.piercanusa.com
Janvier Labs 2022-07-19 - Growth Capital
Le Genest-Saint-Isle, France · www.janvier-labs.com
Doc Generici Srl 2022-06-30 - Secondary Sale
Milan, Italy · www.docgenerici.it
Dental Monitoring SAS 2021-10-21 - Secondary Buyout
Paris, France · www.dentalmonitoring.com
DomusVi SAS 2021-07-02 - Growth Capital
Suresnes, France · www.domusvi.com
Swixx Biopharma SA 2021-05-20 - Growth Capital
Baar, Switzerland · www.swixxbiopharma.com
Plantex 2021-01-28 - Buyout (LBO, MBO, MBI)
Saint-Michel-sur-Orge, France · www.plantex.fr
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
SERB S.a.r.l. 2017-06-09 Wellstat Therapeutics - Vistogard and Xuriden 2023-07-13 2
Luxembourg, Luxembourg · wwwserb.com Rockville, Maryland
Seqens SAS 2016-03-21 Wavelength Pharmaceuticals 2021-08-26 3
Ecully, France · www.seqens.com Petah Tikva, Israel · www.wavelengthpharma.com
SERB S.a.r.l. 2017-06-09 BTG Specialty Pharmaceuticals 2020-12-01 1
Luxembourg, Luxembourg · wwwserb.com Gladwyne, Pennsylvania · www.btgsp.com
CEVA Sante Animale SA 2007-04-25 Thundershirt LLC 2019-07-30 4
Libourne, France · www.ceva.com Durham, North Carolina · www.thundershirt.com
Seqens SAS 2016-03-21 Chemoxy International Ltd. 2017-07-22 2
Ecully, France · www.seqens.com Middlesbrough, United Kingdom · www.chemoxy.com
CEVA Sante Animale SA 2007-04-25 Sogeval SA 2013-12-20 3
Libourne, France · www.ceva.com Laval, France · www.sogeval.fr
CEVA Sante Animale SA 2007-04-25 Vet Brands International, Inc. 2007-07-11 2
Libourne, France · www.ceva.com Miramar, Florida · www.vetbrands.com

M&A by Sector

Sector Current # Value All-time # Value
Life Science 8 (50%) - 10 (50%) -
Medical Products 2 (13%) - 3 (15%) -
Chemicals 2 (13%) - 2 (10%) -
Healthcare Services 1 (6%) - 2 (10%) -
Consumer Services 1 (6%) - 1 (5%) -
Distribution 1 (6%) - 1 (5%) -
Manufacturing 1 (6%) - 1 (5%) -
Total 16 - 20 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
France 11 (69%) - 12 (60%) -
United States 1 (6%) - 2 (10%) -
  California 1 (6%) - 2 (10%) -
Belgium 1 (6%) - 1 (5%) -
Luxembourg 1 (6%) - 1 (5%) -
Netherlands 1 (6%) - 1 (5%) -
Switzerland 1 (6%) - 1 (5%) -
Italy - - 1 (5%) -
Sweden - - 1 (5%) -
Total 16 - 20 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 5 (31%) - 7 (35%) -
Growth Capital 5 (31%) - 6 (30%) -
Secondary Buyout 5 (31%) - 6 (30%) -
Stake Purchase 1 (6%) - 1 (5%) -
Total 16 - 20 -

Exits by Deal Type

Type Total # Value
Secondary Sale 2 (40%) -
Trade Sale - Public Company 2 (40%) -
Trade Sale 1 (20%) -
Total 5 -

Top M&A Advisors

Financial Deals
BNP Paribas Corporate and Investment Banking
1
Barclays Investment Bank
1
Legal Deals
White & Case
1
Gattai, Minoli, Agostinelli & Partners
1

M&A Connections

Deals
Acquired from
Investor(s)
30%
6 (30%)
Strategic(s)
5%
1 (5%)
Exited to
Investor(s)
40%
2 (40%)
Strategic(s)
40%
2 (40%)

FAQ

When was Merieux Equity Partners founded?

Merieux Equity Partners was founded in 2009.

What type of investor is Merieux Equity Partners?

Merieux Equity Partners is a growth capital firm.

Where is Merieux Equity Partners headquartered?

Merieux Equity Partners is headquartered in Lyon, France.

How much capital does Merieux Equity Partners have under management?

Merieux Equity Partners has 1.3B EUR under management.

 Subscribe to unlock this and 204,320
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 77K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.